LHV finantsportaal

Foorum Investeerimine

Börsipäev 9. juuni

Kommentaari jätmiseks loo konto või logi sisse

  • Kreeka kipub juhtima sentimenti Euroopa aktsiaturgudel, kus Stoxx 600 lõpetas -0,9% kaotusega (aprillis keskel saavutatud tipust -7,2%) ning avaldas veidi tugevamat survet ka USA börsil, juhtides S&P 500 -0,7% madalamale. Viimaste uudiste kohaselt ootavad kreeditorid hetkel vastupakkumist Kreekalt, mängides samal ajal järjest rohkem mõttega, et riigi väljumine eurotsoonist poleks suureks probleemiks (Prantsusmaa ja Saksamaa rahandusministrid).

    Wall Streeti eeskujul liikusid öösel allapoole ka Aasia aktsiaturud. Hiinas kauples Shanghai Composite -0,8% madalamal, kui sedapuhku ei suutnud isegi nõrgem makro kutsuda esile täiendavat spekulatsiooni rahapoliitika üle. Hiina tarbijahinnaindeksi kasv aeglustus aprilli 1,5% pealt mais 1,2% peale, mis oli aeglaseim tempo alates jaanuarist ning samuti osutus madalamaks analüütikute 1,3% ootusega võrreldes.

    Hiina tootjahinnaindeksi langus püsis -4,6% peal, vastupidiselt analüütikute loodetud paranemisele -4,5% peale. Analüütikute sõnul on madala inflatsiooni taga tööstuslik ületootmine, pehmem sisenõudlus ja madalamad toorainete hinnad, mis peaks kutsuma keskpanka rahapoliitikat lõdvemaks muutma, sest madal inflatsioon võib vähendada ettevõtete soovi investeerida ja hoida tagasi tarbijate kulutusi, mis ähvardaks riigi majanduskasvu survestada.

    Hiina tarbijahinnaindeks (valge) ja tootjahinnaindeks (kollane)


    Tänase börsipäeva jooksul laekuvad pigem teise järgu majandusnäitajad, kui Euroopas avaldatakse eurotsooni esimese kvartali revideeritud SKP ning Ühendriikides on fookuses JOLTS tööturu küsitlus.

    10.00 Hispaania kinnisvaratehingute arvu muutus (aprill)
    12.00 Eurotsooni esimese kvartali revideeritud SKP
    13.00 USA väikefirmade kindlustunde indeks (mai)
    17.00 USA JOLTS tööturu küsitlus (aprill)
  • Prantsusmaa kumulatiivne eelarve puudujääk oli aprillis -59,8 miljardit eurot, mis oli 4,37 miljardi euro võrra väiksem kui mullu samal ajal
  • Lululemoni kasum rohkem kui kahekordistus lõppenud kvartalis:

    • Lululemon adjusted Q1 EPS 34 cents, same as year-ago
    • Q1 profit rises to $47.8 million from $19 million year-ago
    • Q1 EPS jumps to 34 cents vs.13 cents year-ago
    • Q1 revenue climbs 10% to $423.5 million
    • Lululemon shares climb 2.8% premarket after earnings
  • DAX tipust -12% ning jõudnud RSI järgi lühiajaliselt ülemüüdud tasemele

  • USA väikefirmade kindlustunde indeks paranes mais 98,3 punkti peale vs oodatud 97,2 punkti ja 96,9 punkti aprillis, mis ajalooliselt on viidanud keskpärasele majandusaktiivsusele.

    “The NFIB May survey results confirm that the economy is moving ahead, but at an uninspiring pace. Owners do what is necessary, like hiring workers when needed, to keep up with growth mostly powered by an increasing population.” – Bill Dunkelberg, NFIB Chief Economist

  • Gapping up
    In reaction to strong earnings/guidance:
    MXL +5.6%, (announces revised guidance reflecting Entropic acquisition contribution), PBY +4.3%, PLAY +4.2%, CASY +3.7%, HQY +2.5%, LULU +2.2%, UEC +1.1%, HDS +1%

    M&A news: AU +10.6% (Newmont Mining (NEM) last night announced it would acquire Anglo's Cripple Creek & Victor gold mine for $820 mln), VC +1.2% (completes sale of ownership interest in Halla Visteon Climate Control Corp), GM +0.9% (Fiat Chrysler execs are looking toward hedge funds to support possible General Motors (GM) merger, according to WSJ), ATML +0.8% (following late spike on Reuters report that the company hired advisor to explore options -including sale)

    Select metals/mining stocks trading higher: HMY +4.5%, DRD +2.9%, GFI +1.9%, DNR +1.6%, FCX +1.2%, MT +1.1%, ABX +0.9%, GDX +0.8%, AKS +0.8%, GOLD +0.7%

    Other news: AXN +22.3% (China FDA has issued licenses to its subsidiary to produce Tilidine Hydrochloride tablets), NAVB +17.6% ( announces 'positive' Lymphoseek comparative results in injection site pain study in breast cancer), OCLS +16.5% (receives FDA approval for its Alevicyn SG Antipruritic Spray Gel ), SAGE +15.9% (positive top-line data, from its exploratory trial of SAGE-547 to treat postpartum depression), RXII +10% (received two Notices of Allowance from the USPTO), NBG +3.2% (cont volatility surrounding Greece negotiations), GOMO +3% (Sungy Mobile enters into definitive agreement for going private transaction, for $4.90/share in cash), PGH +1.6% (reports lindbergh production exceeding capacity of 12,500 bbl/d), .

    Analyst comments: AMD +2.6% (initiated with a Outperform at Northland Capital), DEO +1.8% (upgraded to Buy at Natixis Bleichroeder), DG +1.2% (upgraded to Strong Buy at Raymond James)

    Gapping down
    In reaction to disappointing earnings/guidance:
    ZQK -14.5%, FCEL -9.9%, BURL -7.2%, UNFI -6.9%, STV -5.9%, ONCS -5.9%, TPLM -5.7%, SB -5.4%, KANG -3.4%, MLNK -1.7%, HRB -0.8%, SAIC -0.5%

    Other news: NBIX -6.1% (suspended two planned clinical studies ), NSPH -3.6% (announces a registered direct offering for $4.4 million of convertible preferred stock), DB -3.1% (offices were searched by investigators today over issues with client transactions, according to reports), ONCY -2.8% (announced it will initially focus on pursuing registration for REOLYSIN in two indications - the neoadjuvant treatment of muscle-invasive bladder cancer and the treatment of glioblastoma), CHL -2.2% (still checking), NEM -1.7% ( files for 29,000,000 share common stock offering in 424B5; to add profitable production with purchase of Cripple Creek & Victor Mine), AVID -1.5% (proposed $115 million offering of Convertible Senior Notes Due 2020), BBRY -1.5% (unfavorable commentary on Mad Money), ETSY -1.4% (Tiger Global Management disclosed 8.9% passive stake in 13G filing), AAL -1.4% (reports May traffic), HSBC -1% (provides investor update; will look to to sell its operations in Turkey and Brazil)

    Analyst comments: AKAM -2.5% (downgraded to Neutral from Outperform at Macquarie), CTXS -1.4% (downgraded to Sell from Buy at Berenberg)

    Allikas:Briefing.com
  • Erko Rebane
    DAX tipust -12% ning jõudnud RSI järgi lühiajaliselt ülemüüdud tasemele



    Üsna kena 5% põrge kahe päevaga tagasi neutraalse sentimendi juurde

Teemade nimekirja